What is the most common complication of cystic fibrosis (CF) with hyperchloremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bronchiectasis is the Most Common Complication of Cystic Fibrosis

Bronchiectasis is the most common complication of cystic fibrosis with hyperchloremia (elevated sweat chloride). This progressive bronchiectasis is the primary manifestation of CF lung disease, which remains the main cause of morbidity and mortality in CF patients.

Pathophysiology of CF Lung Disease

CF is caused by mutations in the CFTR gene, resulting in abnormal chloride transport across epithelial cells. This leads to:

  • Dehydration of mucosal fluids and abnormal mucin secretion 1
  • Retention of viscous and tenacious secretions in airways 1
  • Impaired mucociliary clearance 2
  • Formation of endobronchial mucus plaques and plugs 2
  • Chronic bacterial infection and inflammation 3

The abnormal CFTR function is detected clinically through elevated sweat chloride levels (hyperchloremia), which is a hallmark diagnostic feature of CF.

Progression to Bronchiectasis

The pathological sequence in CF lung disease follows this pattern:

  1. Small airway disease develops first due to mucus obstruction
  2. Chronic infection establishes (commonly with Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus) 1
  3. Persistent inflammation damages bronchial walls
  4. Bronchiectasis develops and progressively worsens 2

Bronchiectasis is characterized by permanent dilation of bronchi and bronchioles due to destruction of the muscular and elastic components of the bronchial walls. This creates a vicious cycle of impaired mucus clearance, bacterial colonization, and inflammation.

Evidence Supporting Bronchiectasis as the Most Common Complication

Multiple guidelines and research clearly establish bronchiectasis as the predominant complication:

  • Lung disease is "the main cause of morbidity and mortality in patients with CF" 2
  • The natural history of CF "remains one of worsening bronchiectasis and obstructive airways impairment" 4
  • Virtually all CF patients develop bronchiectasis if they survive long enough 1
  • Respiratory failure resulting from progressive bronchiectasis is "the primary cause of death among >90% of persons with CF" 1

Other Pulmonary Complications

While bronchiectasis is the most common complication, other pulmonary complications can develop, particularly as lung disease progresses:

  • Hemoptysis and pneumothorax 1
  • Pulmonary hypertension 5
  • Chronic hypoxic and hypercapnic respiratory failure 5
  • Respiratory infections and exacerbations 1

Non-Pulmonary Complications

CF also causes significant non-pulmonary complications:

  • Pancreatic insufficiency (in >80% of patients) 6
  • Malabsorption and nutritional deficiencies 6
  • Distal intestinal obstruction syndrome 6
  • CF-related diabetes 1
  • Hepatobiliary complications 6

Clinical Implications

Understanding that bronchiectasis is the most common complication of CF has important implications:

  • Early detection and aggressive management of lung disease is critical
  • Regular monitoring of lung function and imaging is essential
  • Airway clearance techniques should be implemented early
  • Prompt treatment of respiratory infections is necessary
  • CFTR modulator therapies may help slow progression of bronchiectasis

Conclusion

Among the options presented (bronchiectasis, empyema, and pulmonary emphysema), bronchiectasis is definitively the most common complication of CF with hyperchloremia. While emphysema can occur in CF patients, particularly in advanced disease, it is not the primary pathological process. Empyema is a potential but relatively uncommon complication that typically occurs during acute infections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cystic Fibrosis Lung Disease: An Overview.

Respiratory care, 2020

Research

Pathogenesis of bacterial bronchitis in cystic fibrosis.

The Pediatric infectious disease journal, 1997

Research

Pulmonary complications in adult patients with cystic fibrosis.

The American journal of the medical sciences, 2008

Research

Pulmonary Complications of Cystic Fibrosis.

Seminars in respiratory and critical care medicine, 2019

Guideline

Gastrointestinal Complications in Cystic Fibrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.